Peptilogics
Latest round
- Series B
Last raised
- Oct 2025
Total raised
- $119M
Investors
- 7
About Peptilogics
Founded in 2013 and based in Pittsburgh, US, Peptilogics, Inc. is a clinical-stage biotechnology company that develops engineered peptide therapeutics to treat life-threatening infections, including prosthetic joint and cystic fibrosis-related lung infections, using a proprietary AI-driven discovery platform.
Who invested in Peptilogics
7 investors across 3 rounds
See all investors in Peptilogics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Peptilogics
Who invested in Peptilogics?
Peptilogics has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Peptilogics raised?
Peptilogics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Peptilogics last raise money?
Peptilogics's most recent round on record is a Series B, in Oct 2025.
What does Peptilogics do?
Founded in 2013 and based in Pittsburgh, US, Peptilogics, Inc.
Where is Peptilogics headquartered?
Peptilogics is headquartered in Pittsburgh, US.
Which VCs invest in companies like Peptilogics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Peptilogics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Peptilogics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.